P388 Cells
| Unit |
5 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Mouse cell lines |
| Organism |
Mouse |
| Donor History |
Mouse lymphoma |
| Growth Properties |
Suspension |
| Growth Conditions |
Culture medium: RPMI 1640 ,w: 2.0 mM stable Glutamine ,w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
P388 is a murine lymphoid neoplasm cell line derived from a spontaneous lymphocytic leukemia in DBA/2 mice. It is commonly used in cancer research, particularly for studying leukemia and testing anti-cancer compounds. P388 cells grow in suspension and exhibit a doubling time of approximately 24 hours under optimal culture conditions. The cells are characterized by their rapid proliferation and high sensitivity to chemotherapeutic agents, making them a valuable tool for evaluating the efficacy of new cancer treatments.
P388 cells express typical markers of lymphoid lineage, including surface immunoglobulins and various cell surface antigens associated with B-cells. Researchers often utilize this cell line in in vivo models by inoculating mice to study tumor growth, metastasis, and response to therapies. Additionally, the P388 cell line serves as a model for investigating the molecular mechanisms underlying leukemia, such as the role of specific oncogenes and tumor suppressor genes.
Despite its widespread use, the P388 cell line has limitations, such as the lack of human relevance and potential genetic drift over extended culture periods. Therefore, researchers often complement studies involving P388 cells with other models to obtain a comprehensive understanding of leukemia biology and treatment responses.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

